Atorvastatin For The Reduction Of Ventricular Arrhythmias
NCT00457340
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
220
Enrollment
INDUSTRY
Sponsor class
Conditions
Arrhythmia
Interventions
DRUG:
Atorvastatin 80mg
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.